Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study
Pivot, Xavier, Prof, Gligorov, Joseph, MD, Müller, Volkmar, Prof, Barrett-Lee, Peter, Prof, Verma, Sunil, Prof, Knoop, Ann, MD, Curigliano, Giuseppe, MD, Semiglazov, Vladimir, Prof, López-Vivanco, Guillermo, MD, Jenkins, Valerie, DPhil, Scotto, Nana, MD, Osborne, Stuart, MSc, Fallowfield, Lesley, Prof
Published in The lancet oncology (01.09.2013)
Published in The lancet oncology (01.09.2013)
Get full text
Journal Article